Oncogenic
PTBP1
SLC2A11–MIF
bladder cancer
fusion protein
mRNA stability
metastasis
Journal
MedComm
ISSN: 2688-2663
Titre abrégé: MedComm (2020)
Pays: China
ID NLM: 101769925
Informations de publication
Date de publication:
Sep 2024
Sep 2024
Historique:
received:
20
12
2023
revised:
03
07
2024
accepted:
14
07
2024
medline:
19
8
2024
pubmed:
19
8
2024
entrez:
19
8
2024
Statut:
epublish
Résumé
Chimeric RNAs, distinct from DNA gene fusions, have emerged as promising therapeutic targets with diverse functions in cancer treatment. However, the functional significance and therapeutic potential of most chimeric RNAs remain unclear. Here we identify a novel fusion transcript of solute carrier family 2-member 11 (
Identifiants
pubmed: 39156764
doi: 10.1002/mco2.685
pii: MCO2685
pmc: PMC11324686
doi:
Types de publication
Journal Article
Langues
eng
Pagination
e685Informations de copyright
© 2024 The Author(s). MedComm published by Sichuan International Medical Exchange & Promotion Association (SCIMEA) and John Wiley & Sons Australia, Ltd.
Déclaration de conflit d'intérêts
The authors declare no conflict of interest.